Aller au contenu principal
Profil bibliographique

Dong‐Chun Hong

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

82Publications signalées
483Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Sarcoma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersCAR-T cell therapy researchLymphoma Diagnosis and TreatmentCancer Research and Treatments

Les publications récentes

Accès ouvert 2026 article OpenAlex

Subcutaneous injection of semaglutide causes increased muscle uptake of 18F-FDG and reduces the imaging quality of PET/CT: a case report

Dong‐Chun Hong, Liyuan Le, Weipeng Chen, Wen Long et autres

Semaglutide, a glucagon-like peptide-1 receptor agonist widely used in diabetes management, has not been previously reported to interfere with PET/CT imaging. This case highlights a novel observation regarding same-day subcutaneous semaglutide injection leading to increased muscular 18 F-FDG uptake, which compromises lesion …

cn (code pays fourni par la source)

1 citation EJNMMI Research
Accès ouvert 2026 article OpenAlex

Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus (Adv. Mater. 7/2026)

Cong Sun, Chu Xie, Xin‐Yan Fang, Dong‐Chun Hong et autres

EBV Vaccine Cong Sun, Zheng Liu, Mu-Sheng Zeng, and colleagues design a chimeric nanoparticle displaying multiple EBV glycoproteins in virion-mimicry pattern. It induces potent neutralizing antibodies against Epstein-Barr virus. This vaccine offers a new strategy to comprise multiple antigens upon nanoparticle to …

cn (code pays fourni par la source)

0 citations Advanced Materials
Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Figure S3 from Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade

Dong‐Chun Hong, Jing Yang, Cong Sun, Yuan-Tao Liu et autres

Comparison between RIS group and SARC group in mRNA-seq and WES data.(A) Expression levels of IDO and CTLA-4 in the RIS group and SARC group in mRNA-seq.(B) The anti-tumor immunity score and the proliferation module score of the RIFS group and the …

0 citations
Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Figure S4 from Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade

Dong‐Chun Hong, Jing Yang, Cong Sun, Yuan-Tao Liu et autres

The landscape of copy number variants and results for blood detection.༈A༉Top genes in copy number changes in RIS and SARC groups filtered by COSMIC gene list.༈B༉Top genes in copy number changes in RIFS and FS subtypes.༈C༉Top genes in copy number changes in …

0 citations
2025 article OpenAlex

Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus

Cong Sun, Chu Xie, Xin‐Yan Fang, Dong‐Chun Hong et autres

Epstein‒Barr virus (EBV) is a ubiquitous gammaherpesvirus linked to a broad spectrum of malignancies and autoimmune diseases with no approved therapeutic drugs or vaccines. EBV infection relies on the viral glycoproteins gB and gHgL, which, together, function as the fusion apparatus, mediating …

cn (code pays fourni par la source)

6 citations Advanced Materials
Accès ouvert 2025 article OpenAlex

Loss of TACC2 impairs chemokine CCL3 and CCL4 expression and reduces response to anti-PD-1 therapy in soft tissue sarcoma

Jing Yang, Xiuxia Lu, Qiyan Cai, Mengmeng Liu et autres

BACKGROUND: Soft tissue sarcoma (STS) is a rare, heterogeneous malignancy with limited treatment options for metastatic disease. Despite advances in immunotherapy, including PD-1 inhibitors, clinical outcomes remain suboptimal, highlighting the need for novel biomarkers and therapeutic strategies. This study investigated the role …

cn (code pays fourni par la source)

9 citations Molecular Cancer
2025 conference-abstract OpenAlex

A phase II, multicenter trial of the combination of chidamide and toripalimab in patients with advanced soft tissue sarcoma: Efficacy updates.

Xing Zhang, Ruiqing Peng, Peng Zhang, Wenhua Zhan et autres

11560 Background: Chidamide is an oral subtype-selective histone deacetylase (HDAC) inhibitor which is effective on the patients with hematological tumors and could be hoped to enhance the efficacy of checkpoint blockade therapies and regulate the host immune response. Here, we report the …

cn (code pays fourni par la source)

0 citations Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.